Evidence map›Paper›PMID 31258591›Full record

ArticlePakistan journal of medical sciences2019

Novel compound heterozygous mutations in

Muhammad Imran Naseer, Mahmood Rasool, Angham Abdulrahman Abdulkareem, Adeel G Chaudhary, Syed Kashif Zaidi, Mohammad H Al-Qahtani

Open access · goldAbstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Muhammad Imran NaseerMuhammad Imran Naseer, Center of Excellence in Genomic Medicine Research, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia. Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Mahmood RasoolMahmood Rasool, Center of Excellence in Genomic Medicine Research, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia. Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Angham Abdulrahman AbdulkareemAngham Abdulrahman Abdulkareem, Center of Excellence in Genomic Medicine Research, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia. Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Adeel G ChaudharyAdeel G. Chaudhary, Center for Innovation in Personalized Medicine, Faculty of Applied Medical Sciences, Center of Excellence in Genomic Medicine Research, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia. Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Syed Kashif ZaidiSyed Kashif Zaidi, Center of Excellence in Genomic Medicine Research, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia. Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
Mohammad H Al-QahtaniMohammad H. Al-Qahtani, Center of Excellence in Genomic Medicine Research, King Abdulaziz University, 21589, Jeddah, Kingdom of Saudi Arabia. Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
King Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePrimary microcephaly (MCPH) is a rare autosomal recessive disorder characterized by impaired congenital reduction of brain size along with head circumference and intellectual disability. MCPH is a heterogeneous disorder and more than twenty four genes associated with this disease have been identified so far. The objective of this study was to find out the novel genes or mutations leading to the genetic defect in a Saudi family with primary microcephaly.

methodsWhole exome sequencing was carried out to find the novel mutation and the results was further validated using Sanger sequencing analysis. This study was done in the Center of excellence in Genomic Medicine and Research, King Abdulaziz University under KACST project during 2017 and 2018.

resultsWe report a novel compound heterozygous mutations c.797C>T in exon 7 and c.1102G>A in exon 9 of the WD repeat domain 62 (WDR62) (OMIM 604317) gene in two affected siblings in Saudi family with intellectual disability, speech impediments walking difficulty along with primary microcephaly. Two rare, missense variants were detected in heterozygous state in the

conclusionsA compound heterozygous mutations c.797C>T in exon 7 and c.1102G> A in exon 9 of the

Indexed as

Compound heterozygous mutationPrimary MicrocephalySaudi FamilyWDR62

Identifiers

PMID31258591
PMCPMC6572970
OpenAlexW2944374332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.